
Pfizer Inc. (PFE) – Vaccine Success leading the growth
in Company Report , Healthcare & Life Sciences , Pharma & Biotech on August 23, 2021In July 2021, Pfizer issued a voluntary recall in the U.S. for twelve lots of Chantix due to the presence of a nitrosamine, N nitroso varenicline, above the Pfizer established acceptable daily intake level. Nitrosamines are common in water and foods and everyone is exposed to some level of nitrosamines.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast.
– Economic Value Added Analysis
– DCF Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Developments
– M&A Deals
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
CrispIdea Coverage
No of Pages : 43